SCHEMBL28528322

SCHEMBL28528322

COc1cccn2nc(C(=O)O)c(C(=O)O)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA7 P43166 1/20 0.49
CA9 Q16790 1/20 0.49
CA14 Q9ULX7 1/20 0.49
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
PKM P14618 1/20 0.40
ATM Q13315 3/20 0.37
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
FABP4 P15090 1/20 0.37
GAA P10253 1/20 0.37
HTT P42858 1/20 0.36
TP53 P04637 1/20 0.36
RORC P51449 1/20 0.36
JAK2 O60674 1/20 0.36
PPARA Q07869 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL682711 0.77 GAA (0.40) CA12CA1CA2CA7CA9
SCHEMBL31017418 0.76 CA12 (0.39) CA12CA1CA2CA7CA9
SCHEMBL28515674 0.75 ALDH1A1 (0.40) CA12CA1CA2CA7CA9
SCHEMBL683872 0.73 ALDH1A1 (0.59) CA12CA1CA2CA7CA9
SCHEMBL3461693 0.73 TP53 (0.43) KMT2AMEN1POLBSMN1; SMN2GAA
SCHEMBL21816279 0.72 IRAK4 (0.47) CA12CA1CA2CA7CA9
SCHEMBL3459022 0.71 MAPT (0.40) KMT2AMEN1PKMPOLBSMN1; SMN2
SCHEMBL19128307 0.69 MAP3K14 (0.34) KMT2AATMGAAHTTJAK2
SCHEMBL7354285 0.69 HTR3A (0.55) CA12CA1CA2CA7CA9
SCHEMBL22148137 0.69 CA12 (0.46) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117164582-A Protease inhibitor, pharmaceutical composition and application thereof 周龙兴 2023-12-05 CN disclosed
CN-112074522-B Compounds as protease activated receptor 4(PAR4) inhibitors for the treatment of platelet aggregation 深圳信立泰药业股份有限公司 2022-08-26 CN disclosed
CN-112074522-A Compounds as protease activated receptor 4(PAR4) inhibitors for the treatment of platelet aggregation 深圳信立泰药业股份有限公司 2020-12-11 CN disclosed